ID
5
Cancer Name
Prostate Cancer
Main Grouping
Endocrine/Reproductive
Organ System
Prostate
Cell Origin
Luminal epithelial cells (acinar glandular cells)
Pathways Affected
Prostate cancer is driven by dysregulation across multiple interconnected molecular signaling pathways. The androgen receptor (AR) signaling pathway is the central driver of prostate cancer growth and progression. AR is a ligand-dependent nuclear transcription factor activated primarily by testosterone and dihydrotestosterone (DHT). Upon ligand binding, AR undergoes nuclear translocation and binds androgen response elements (AREs) on DNA, initiating transcription of genes governing cellular differentiation, proliferation, survival, and PSA production. Castration-resistant prostate cancer (CRPC) arises when AR signaling is reactivated despite low androgen levels through AR amplification, mutation, or splice variants such as AR-V7.
The PI3K/AKT/mTOR pathway is activated in a substantial proportion of prostate cancers, frequently through loss-of-function mutation or deletion of the tumor suppressor PTEN. Activated AKT promotes cell survival, inhibits apoptosis, and stimulates mTOR-dependent protein synthesis and proliferation. Extensive crosstalk exists between the PI3K/AKT/mTOR pathway and AR signaling, with mutual feedback contributing to therapeutic resistance. The RAS/MAPK (ERK) pathway also interacts with AR and PI3K signaling to regulate proliferation and survival.
The WNT/β-catenin pathway is frequently activated in advanced and castration-resistant disease, promoting tumor cell invasion and metastasis. Nuclear β-catenin acts as a co-activator for AR, further amplifying androgen-independent signaling. NF-κB signaling drives pro-inflammatory gene expression, anti-apoptotic signaling, and angiogenesis. The JAK/STAT3 pathway contributes to immune evasion, stemness, and resistance to apoptosis. Dysregulation of apoptosis pathways and cell cycle regulation allows prostate cancer cells to evade programmed cell death and sustain uncontrolled proliferation. Growth factor pathways including EGF/EGFR and IGF-1/IGF-1R further support tumor progression and resistance mechanisms.
Description
Prostate cancer is the most commonly diagnosed solid tumor in men in the United States and the second leading cause of cancer death among American men, following only lung cancer. In the United States, approximately 288,300 new prostate cancer cases are diagnosed annually with approximately 34,700 deaths per year. Globally, approximately 1.47 million new prostate cancer cases are diagnosed annually with approximately 396,000 deaths — making prostate cancer the second most common cancer in men worldwide and the fifth most common cancer overall. Prostate cancer incidence is highest in North America, Northern Europe, and Australia; lower in Asia (though Asian incidence is rising with Western dietary adoption).
Prostate cancer demonstrates the widest range of biological behavior of any common malignancy — from indolent, low-grade localized disease that may never cause symptoms or require treatment (managed by active surveillance), to aggressive high-grade metastatic disease with poor prognosis. The Gleason grading system (revised 2014 and replaced by Grade Groups 1-5) is the standard pathological grading system based on histological architecture: Grade Group 1 (Gleason 3+3 = 6 — indolent, rarely lethal); Grade Group 2 (3+4 = 7 — intermediate with mostly 3 pattern); Grade Group 3 (4+3 = 7 — intermediate with mostly 4 pattern); Grade Group 4 (4+4, 3+5, 5+3 = 8 — high risk); Grade Group 5 (4+5, 5+4, 5+5 = 9-10 — very high risk).
The defining molecular feature of prostate cancer is the central dependence on androgen receptor (AR) signaling — testosterone is converted peripherally and intratumorally to the more potent dihydrotestosterone (DHT) by 5α-reductase; DHT binds AR with ~5x higher affinity than testosterone; the AR/DHT complex translocates to the nucleus, dimerizes, and binds androgen response elements (AREs) in the promoters of target genes including PSA/KLK3, NKX3.1, TMPRSS2, and cell cycle/survival genes; androgen deprivation therapy (ADT) is the backbone of advanced prostate cancer treatment; castration-resistant prostate cancer (CRPC) develops in virtually all men on ADT through multiple resistance mechanisms: AR amplification (~50-80%), AR ligand-binding domain mutations allowing activation by weak androgens, AR splice variants (AR-V7 — lacks ligand-binding domain, constitutively active), intratumoral androgen synthesis, and bypass pathways through PI3K/AKT, WNT/beta-catenin, or neuroendocrine transformation.
The most relevant plant phytochemical laboratory evidence uses the three standard prostate cancer cell lines: LNCaP (androgen-sensitive, wild-type p53, PTEN-null — representing hormone-sensitive PCa), PC-3 (androgen-independent, p53-null — representing CRPC without functional p53), and DU145 (androgen-independent, mutated p53 — representing CRPC); quercetin confirmed to inhibit PI3K/Akt pathway in LNCaP cells; modulate BAX/BIM/PUMA/NOXA apoptosis machinery in all three cell lines; disrupt mitochondrial membrane potential in LNCaP cells confirmed (PMC6001031).
Plant-Based Description
Plant-based dietary patterns have been associated with reduced risk and slower progression of prostate cancer in multiple epidemiological studies. Foods rich in phytochemicals—including tomatoes, cruciferous vegetables such as broccoli, cauliflower, and Brussels sprouts, legumes including soy and lentils, pomegranate, green tea, garlic, and flaxseed—have each received documented research interest. These foods deliver bioactive compounds including lycopene, sulforaphane, indole-3-carbinol, isoflavones (genistein, daidzein), ellagitannins, epigallocatechin-3-gallate (EGCG), curcumin, allicin-derived organosulfur compounds, and secoisolariciresinol diglucoside (SDG) lignans. Each of these compounds has been studied in relation to molecular pathways implicated in prostate tumor biology. Whole plant food dietary patterns emphasizing legumes, cruciferous and allium vegetables, whole grains, fruits, nuts, and seeds are the primary dietary context investigated across cell, animal, and clinical research models for prostate cancer risk and progression.
Plant Chemistry Detail
Lycopene is a lipophilic carotenoid abundant in tomatoes and processed tomato products and has been studied for its interaction with oxidative stress and androgen signaling pathways.
Sulforaphane, an isothiocyanate derived from glucoraphanin in cruciferous vegetables including broccoli, Brussels sprouts, and cauliflower, induces phase II detoxification enzymes through Nrf2 pathway activation and has been studied for apoptosis and cell cycle regulation.
Epigallocatechin-3-gallate (EGCG) from green tea is a polyphenolic catechin that has been studied in relation to PI3K/AKT, NF-κB, and androgen receptor signaling.
Genistein and daidzein, isoflavones found in soybeans and edamame, interact with androgen receptor signaling and estrogen receptor beta pathways. Punicalagins and ellagic acid from pomegranate are hydrolysable tannins studied for anti-proliferative and inflammatory pathway interactions.
Curcumin from turmeric has been studied for NF-κB, androgen receptor, and Wnt/β-catenin pathway modulation. Secoisolariciresinol diglucoside (SDG) from flaxseed is converted into enterolignans by gut microbiota.
Organosulfur compounds from garlic have been studied in relation to apoptosis and cell cycle signaling. Quercetin, present in onions, apples, and kale, has been studied for interactions with androgen receptor and PI3K/AKT signaling.
Nutritional Focus
Dietary priorities in prostate cancer research include lycopene from cooked tomatoes, sulforaphane from cruciferous vegetables, isoflavones from whole soy foods and edamame, EGCG from brewed green tea, SDG lignans from ground flaxseed, curcumin from turmeric, punicalagins from pomegranate, and organosulfur compounds from garlic and allium vegetables. Plant-sourced ALA omega-3 fatty acids from ground flaxseed, chia seeds, hemp seeds, and walnuts are relevant dietary omega-3 sources in a plant-based context. Zinc from pumpkin seeds and legumes, selenium from Brazil nuts, and vitamin D from fortified plant foods and sunlight exposure are also documented research areas. Dietary fiber from whole grains, legumes, vegetables, and fruits supports gut microbiome diversity relevant to lignan conversion and systemic inflammation modulation.
Research Notes
SELECT trial (2009, NEJM — Lippman et al.): Randomized controlled trial found no protective effect from single-agent selenium or vitamin E supplementation; the vitamin E arm was later associated with increased prostate cancer risk in extended follow-up.
Thomas et al. (BJU International, 2014): Double-blind randomized controlled trial of a combined broccoli, turmeric, pomegranate, and green tea whole-food supplement in localized prostate cancer on active surveillance showed significant PSA rise reduction versus placebo.
Demark-Wahnefried et al. (Cancer Epidemiology, Biomarkers & Prevention, 2008): Ground flaxseed supplementation before radical prostatectomy was associated with reduced tumor proliferation rates and lower PSA.
Ornish et al. (Journal of Urology, 2005): Intensive whole-food plant-based lifestyle intervention in men with low-risk prostate cancer on watchful waiting showed PSA decline in the intervention group compared with PSA rise in the control group at 12 months.
Kenfield et al. (Journal of Clinical Oncology, 2014): Healthy plant food intake patterns were associated with prostate cancer-specific mortality outcomes in the Health Professionals Follow-Up Study.
Barnard et al. (Proceedings of the National Academy of Sciences, 1995): Serum from men consuming plant-based diets demonstrated greater inhibition of LNCaP prostate cancer cell growth in vitro compared with omnivore serum.
Notes Visibility
show
Key Foods
Tomato, Broccoli, Soybeans (Edamame), Flaxseed, Pomegranate, Green Tea, Turmeric, Garlic, Kale, Cauliflower, Brussels Sprouts, Pumpkin Seeds, Walnuts, Shiitake Mushroom, Lentils, Brown Rice, Sesame Seeds, Maitake Mushroom., Leek,Avocado,Artichoke,Endive,Radish,Radicchio,Fig,Tangerine,Dragon Fruit Red, Red Onion
Linked Nutrients
Zinc, Selenium from plant sources including Brazil nuts and pumpkin seeds, Vitamin D, Vitamin E including gamma-tocopherol from nuts and seeds, alpha-linolenic acid from flaxseed, chia, hemp, and walnuts, folate, lycopene, sulforaphane, EGCG, genistein, SDG lignans, curcumin, quercetin, soluble dietary fiber, and insoluble dietary fiber.
